Reaction
Joint Instability reporting signals
As of the last recalculation, Joint Instability appears in 1,354 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 19.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methylprednisolone Acetate | 10 | 19.3 | 19.4 |
| Cyclobenzaprine Hydrochloride | 8 | 13.8 | 13.8 |
| Asfotase Alfa | 8 | 12.3 | 12.4 |
| Misoprostol | 7 | 11.1 | 11.1 |
| Abaloparatide | 17 | 9.0 | 9.0 |
| Dalfampridine | 37 | 8.1 | 8.1 |
| Mirabegron | 19 | 7.6 | 7.6 |
| Ocrelizumab | 30 | 7.6 | 7.6 |
| Oxycodone And Acetaminophen | 10 | 6.6 | 6.6 |
| Acalabrutinib | 5 | 6.4 | 6.4 |
| Teriflunomide | 15 | 5.1 | 5.1 |
| Medroxyprogesterone Acetate | 15 | 4.7 | 4.7 |
| Ravulizumab | 4 | 4.6 | 4.6 |
| Sarilumab | 7 | 4.1 | 4.1 |
| Emicizumab | 3 | 3.7 | 3.7 |
| Valbenazine | 4 | 2.4 | 2.4 |